Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Up 921.9% in April

Vivos Therapeutics, Inc. (NASDAQ:VVOS) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 191,100 shares, a growth of 921.9% from the March 31st total of 18,700 shares. Currently, 7.6% of the shares of the company are short sold. Based on an average daily volume of 210,400 shares, the days-to-cover ratio is presently 0.9 days.

Vivos Therapeutics Stock Down 4.3 %

Shares of VVOS opened at $2.46 on Friday. Vivos Therapeutics has a twelve month low of $2.37 and a twelve month high of $48.79. The stock’s 50 day moving average is $4.11 and its two-hundred day moving average is $6.77.

Vivos Therapeutics (NASDAQ:VVOS) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($3.05) earnings per share for the quarter. Vivos Therapeutics had a negative net margin of 98.42% and a negative return on equity of 665.17%. The business had revenue of $3.25 million during the quarter.

Institutional Investors Weigh In On Vivos Therapeutics

A hedge fund recently bought a new stake in Vivos Therapeutics stock. Armistice Capital LLC acquired a new stake in Vivos Therapeutics, Inc. (NASDAQ:VVOS) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 57,000 shares of the company’s stock, valued at approximately $709,000. Armistice Capital LLC owned approximately 4.29% of Vivos Therapeutics at the end of the most recent quarter. 26.35% of the stock is owned by institutional investors and hedge funds.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.